Feasibility Study of the Intensive Systolic Blood Pressure Control
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT02817503
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT02817503
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02817503. Randomized; single masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Feasibility Study of the Intensive Systolic Blood Pressure Control
- Condition
- Hypertension
- Condition
- Hyperhomocysteinemia
- Intervention (Drug)
- Standard BP control
- Intervention (Drug)
- Moderate BP control
- Intervention (Drug)
- Intensive BP control
- Lead sponsor
- Second Affiliated Hospital of Nanchang University
- Collaborator
- Peking University First Hospital
Record details
- Record id
cardio:ct-nct02817503- Content hash
e36c86a329f98f7b9f7784f768c3907b0a6bbf1dcd64517d1db67bedcdf8cbe0